Ivermectin therapy for young children with scabies infection: a multicentre phase 2 non-randomized trialResearch in context

• मुख्य लेखकों: Amanda Gwee (लेखक), Andrew Steer (लेखक), Khampheng Phongluxa (लेखक), Chanthaly Luangphaxay (लेखक), Khanpaseuth Senggnam (लेखक), Ammala Philavanh (लेखक), Alice Lei (लेखक), April Martinez (लेखक), Shan Huang (लेखक), Brett McWhinney (लेखक), Jacobus Ungerer (लेखक), Stephen Duffull (लेखक), Wenyu Yang (लेखक), Xiao Zhu (लेखक), Ben Coghlan (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Elsevier, 2024-08-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Summary: Background: Ivermectin, an effective treatment for scabies, is not licensed for children weighing <15 kg. Pharmacokinetic modelling has shown a 3 mg dose in young children (2-4 years, weighing 10-14 kg) achieves comparable drug exposure to a 200 μg/kg dose in children aged ≥5 years. This...